Companies
Sinocare
Companies like Sinocare have successfully launched affordable CGM systems like iCan, competing actively on price in Asia and Europe.
- Country
- China
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Capacity | Annual capacity of 5 million glucose meters and 2 billion glucose test strips | m.made-in-china.com |
| Certification | Holds ISO 9001, ISO 13485, MDSAP, IVDR, and MDR certifications, plus ISO/IEC 27001:2022 information security certification (2026-06-30) | sinocare.com |
| Regulatory approval | Holds 165 valid Chinese medical device registration certificates, 2 US FDA certificates (3 products), 13 CE certificates (51 products), and 25 CE self-declarations (80 products) for the parent company, plus additional registrations for subsidiaries PTS and Trividia (2026-06-30) | sinocare.com |
| Production site | 9 global R&D and production bases | static.cninfo.com.cn |
| Headcount | Approximately 3,545 employees medium confidence | m.made-in-china.com |
| Revenue | 4,659.34 million CNY for full year 2025 (2025-12-31) | uk.marketscreener.com · marketscreener.com |
Independent sources: m.made-in-china.com · marketscreener.com · static.cninfo.com.cn · uk.marketscreener.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Wearable biodiagnostics | diagnostics-medtech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.